MASK, OXYGEN

The contract solicitation SPE2DS-26-T-270Y, issued by the Defense Logistics Agency under the Department of Defense, seeks the procurement of two oxygen masks identified by NSN 6515-01-519-6766, with a required delivery date of July 28, 2026, and delivery terms FOB Destination to Fort Stewart, Georgia. The acquisition is governed by a firm-fixed-price structure inferred from FAR clause 52.216-1 ALT I, though the official contract type is not explicitly stated. All items must comply with stringent packaging and marking standards including MIL-STD-2073-1E and the Medical Marking Standard No. 1, which supersedes MIL-STD-129 for medical items; labeling must adhere to Hazard Communication Standard 29 CFR 1910.1200 for hazardous materials and MIL-STD-129 for radioactive substances only. The supplies must be delivered in sealed unit containers within commercial shipping containers using the lowest applicable freight rate, with preservation procedures aligned to MIL-STD-2073-1E. Inspection and acceptance occur at the destination point under FAR 52.246-2, with the Government retaining authority to verify conformance to all technical, safety, and quality requirements, including FDA 21 CFR §868.5580 for Class II medical devices and DLA’s RA001 technical list. The contract imposes extensive compliance obligations under DFARS and FAR clauses, including cybersecurity mandates through 252.204-7012 requiring NIST SP 800-171 safeguards and incident reporting, prohibitions against hexavalent chromium and covered defense telecommunications equipment under 252.204-7018, and restrictions on waste handling and storage of toxic materials via 252.223-7006. Contractors must uphold ethical standards through whistleblower rights notification (252.203-7002), restrictions on compensating former DoD officials (252.203-7000), and prohibitions on mandatory arbitration agreements related to sexual assault or harassment (252.222-7006). Representations required from offerors include Unique Entity Identifier and CAGE Code, Small Business status, and disclosures for joint ventures or covered